Dyslipidemia Event

• A. Deputy Minister for Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia.
• Founding president of the Saudi Society of Clinical Pharmacy.
• Professor at Al-Faisal University, School of Medicine and Pharmacy.
• Editor-in-chief of the Saudi Journal of Clinical Pharmacy.
• Fellow of the American College of Chest Physicians, the American Society of Transplantation, the American College of Clinical Pharmacy and of the American Society of Health System Pharmacy.
• Holds several consultancy positions at the World Health Organization, Saudi Food and Drug Authority, and the Saudi Commission for Health Specialties.
• Published more than 50 original peer-reviewed research papers.

•Advisor and Assistant Deputy Minister for Therapeutic Supportive Services, MOH.
• Director of Drug Policy and Regulation Division.
• She was appointed as the Head of National Drug Information Center at the Ministry of Health in 2015, established more than 50 centers across the kingdom.
• Responsible for MOH formulary management and was recently appointed as Drug Policy and Regulation Manager.
• Board member of the Pharmacy Profession Society under SCFHS.
• Board member of the Saudi Clinical Pharmacy Society.

• Consultant of Pediatric Endocrinology and Diabetology, head of Central Committee of Diabetes MOH.
• AFSA Pediatric Endocrinology and Diabetology Paris 5 university, Paris, France (2004- 2005).
• DIU Pediatric Endocrinology and Diabetology Paris 5 university, Paris, France (2005 – 2007).
• Pediatric Endocrinology and Diabetology fellowship, Necker Hospital for Sick Children, Paris, France (2007).
• Saudi Council qualification as pediatric endocrinology and diabetology consultant (2007).
• Has 10 publications in the field of pediatric endocrinology and diabetes.

• Director General of the National Heart Center – Saudi Health Council
• Advisor and General Supervisor of Cardiac Services Improvement Initiative/ MOH, KSA
• Advisor to the Assistant Minister of Health on healthcare strategy and reform
• Consultant Cardiac Surgeon, Heart Failure/Heart Transplant Surgeon Ministry of Health, Riyadh, KSA.
• Established and started:
- the Cardiac surgery service at Hail Heart Center, Al Qurrayat, and Al-Jouf, Saudi Arabia.
- the commissioning of the Cardiac services at King Abdullah Medical Complex in Jeddah, and Tabuk, Saudi Arabia.

• Professor of Medicine, Biochemistry and Molecular Genetic.
• Consultant of the Lipid Clinic, King Abdulaziz University Hospital.
• Dean of Medicine and Applied Medical Sciences, University of Jeddah.
• President of the Saudi Society for Laboratory Medicine.
• Physician-Scientist at King Abdulaziz University and an Adjunct Professor at McGill University, Canada and University of Southern California, USA.
• Author of a book, chapters and more than 100 peer review publications in highly-cited peer-reviewed Journals like the Lancet and Circulation.

• Consultant in General Cardiology and Interventional Cardiology; Ministry of Health.
•Attended the Royal Free Hospital School of Medicine and graduated from the University of London in 1983, with honors in clinical pharmacology & therapeutics.
•Cardiology Fellowship training was at East Birmingham and Queen Elizabeth Hospitals in Birmingham, England.
•Published more than 30 papers and took part in writing national guidelines on heart failure, chronic coronary syndromes and dyslipidemia.

• Director of Pediatric Lipid Program, and the deputy Chairman, department of Pediatrics at King Abdullah Specialized Children Hospital, Ministry of National Guard, Riyadh and Associate Professor, and associate Dean, office of Research, college of Public Health & Health Informatics, King Saud Bin Abdulaziz University for Health Science.
• Received his Pediatric Endocrine training in Vancouver, Canada and completed a Master of Health Sciences from the University of British Columbia.
• Formal Chairman of Saudi Board Pediatric Training Committee in Central Region, and clinician educator in CanMEDS Collaborating Center.

• Cardiologist Director of the cardiology basic science laboratory at the Faculty of Medicine University of Geneva, Switzerland.
• He is an expert in the field of cardiology, in particular with regard to the development and progression of atherosclerosis diseases.
• After obtaining his MD at the University of Geneva, he studied internal medicine and cardiology at Geneva University Hospital and completed a post-doctoral fellowship in the laboratory of Prof. Peter Libby, Boston (1995-1999).
• Following his return to Switzerland in 2000, he became full Professor of cardiology, and in 2006 he was appointed Head of the cardiology department at Geneva University Hospital.
• Between 2012-14, he was the President of the Swiss Society of Cardiology.
• He is the author of more than 500 high impact factor publications and responsible of several Swiss cohorts of atherothrombotic patients, strongly implicated in clinical research in the field of prevention, especially lipidology.
• He was one of the 3 co-chairs of the ESC 2019 Lipid Guidelines and is co-chairing the ESC 2021 Prevention Guidelines.

• Chairman at King Faisal Cardiac Center.
• Adult Cardiology and intervention Echocardiography Consultant.
• Director of Postgraduate Medical Education-DPE at King Abdulaziz Medical City, Ministry of National Guard Health Affair.
• Assistant Professor of Medicine and Cardiology, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.

• Endocrine Consultant, King Fahad Medical City, Riyadh, KSA
• American Board of Clinical Lipidology (2008)
• American Board of Clinical Hypertension (2009).
• Fellow of American College of Physician
• Fellow of American College of Endocrinology
• Endocrine Consultant and Thyroid Oncologist in Obesity, Metabolic and Endocrine Centre at KFMC, Riyadh and Associate Professor at FOM, King Saud Bin Abdul-Aziz University for Health Sciences.
• authored 2 books in Arabic: Life without diabetes and Vitamin D…The magic Vitamin.

• Consultant Lipidologist Metabolic Physician
• Honorary Consultant at Cambridge Universities NHS Trust
• He conducts numerous clinical phase 2, 3 and 4 trials in lipids, diabetes and obesity.
• Authored more than 150 papers in peer reviewed medical journals including The Lancet, Diabetes Care, and Lancet Diabetes Endocrinology.
• Author of several chapters in medical textbooks, and co-author of a book on Cardiovascular Risk
• Served as a topic expert for various reviews by NICE such as the Familial Hypercholesterolaemia Quality Standards (QS41) and Technology Appraisals for PCSK9 inhibitors.

• Consultant Cardiologist and Electrophysiologist at Cleveland Clinic Abu Dhabi.
• Former Internal Medicine Residency Program Director at Al Ain Hospital, Al Ain, United Arab Emirates.
• Clinical Assistant Professor of Cardiovascular Disease at Warren Alpert School of Medicine, Brown University.
• Has been involved in multiple clinical trials; his extensive research on cardiovascular diseases has been published in several multi-center clinical trials and publications.
• Fellow of the American College of Cardiology, Heart Rhythm Society, the American College of Physicians, and Egyptian American Medical Association.

• Consultant Endocrinologist at Obesity, Endocrine and Metabolism Center, KFMC, Riyadh
• American Board in Clinical Lipidology (2023).
• Fellowship in Lipidology and Cardiovascular Disease Prevention from University of British Columbia, Vancouver, BC Canada (2022-2023).
• Saudi Fellowship in Adults Endocrinology (2019 – 2021).
• Saudi Board in Internal Medicine (2014 – 2018).

• Consultant at King Faisal Specialist Hospital and Research Center.
• Adjunct Assistant Professor at Alfaisal University.
• Completed his residency training at Drexel University in Philadelphia.
• Pursued further specialization in Cardiology at the University of Alberta in Edmonton, Canada.
• Holds American and Canadian board certifications in Internal Medicine, Cardiology, and Echocardiography.
• Research interests are focused on Familial Hypercholesterolemia, Cardio-oncology, and Valvular Heart Disease in Pregnancy.
• Published a registry on patients with Homozygous Familial Hypercholesterolemia.